Discover the strategies biopharma GCs are using to navigate FDA shifts, pricing reform, AI governance and crossborder risk across two focused days of curated sessions.
Connect with senior in-house counsel from leading biotechs and pharmaceutical companies during highvalue networking designed for meaningful GCtoGC exchange.